This advertisement has not loaded yet, but your article continues below. Canada on Friday said Pfizer and partner BioNTech COVID-19 vaccine was authorized for use in children aged 5 to 11, making it…
This advertisement has not loaded yet, but your article continues below. Nov 19, 2021 •
The vaccine is 90.7 percent effective at preventing COVID-19 in kids with no serious side effects, Health Canada said.
Kathryn Corzo — an oncology veteran and the program head behind Sanofi’s multiple myeloma monoclonal antibody isatuximab — is now in the C-suite. The newest member at cell therapy player bit.bio as…
SUZHOU and SHANGHAI, China, and PALO ALTO, Calif., Nov. 19, 2021 /PRNewswire/ — Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global clinical-stage biopharmaceutical company dedicated to…
Drug Discovery Service Market 2021-2026
Straits Research has recently added a new report to its vast depository titled Global Drug Discovery Service Market. The report studies vital factors about the Global Drug Discovery Service Market that are essential to be understood by existing as
Gilead is going all in — hook, line and sinker — on its oncology alliance with Arcus. And they are going for broke. The big biotech unveiled a deal that now delivers $725 million in opt-in payments…
Pfizer’s pill to treat Covid-19 is outpacing its top rival from Merck not only in terms of efficacy data but now in the size of its US government contract, too. The US on Thursday announced it will…
Two big things are going on right now at Novartis that have the investor crowd on high alert. First, CEO Vas Narasimhan has signaled he’s now ready to sell or spin off the big generics arm, Sandoz. In…
Merck is making room for yet another use on its Keytruda label — this time, as the first adjuvant immunotherapy for certain renal cell carcinoma patients after they’ve had kidney surgery. The FDA has…
